There is almost no copy number variation (CNV) of RRM1 and RRM2 genes in common types of cancers, whereas RRM2B displays CNV gain in more than 3% of breast cancers, liver cancers, stomach cancers and urinary tract cancers. This evidence concerns the gene RRM2 and breast carcinoma.